Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN GLULISINE for Diabetes mellitus management: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where INSULIN GLULISINE was used for Diabetes mellitus management.

Most Reported Side Effects for INSULIN GLULISINE

Side Effect Reports % Deaths Hosp.
Blood glucose increased 736 21.3% 10 173
Hypoglycaemia 417 12.1% 8 200
Hyperglycaemia 280 8.1% 5 130
Drug ineffective 277 8.0% 1 40
Blood glucose decreased 194 5.6% 4 46
Blood glucose abnormal 162 4.7% 12 47
Diabetes mellitus inadequate control 156 4.5% 0 33
Malaise 147 4.3% 4 73
Glycosylated haemoglobin increased 140 4.1% 0 64
Dizziness 138 4.0% 12 43
Product storage error 131 3.8% 1 17
Visual impairment 124 3.6% 0 20
Blood glucose fluctuation 102 3.0% 25 21
Cerebrovascular accident 95 2.8% 25 53
Fall 95 2.8% 4 55

Other Indications for INSULIN GLULISINE

Diabetes mellitus (924) Type 2 diabetes mellitus (921) Type 1 diabetes mellitus (569) Product used for unknown indication (293) Blood glucose increased (15) Hyperglycaemia (14) Insulin-requiring type 2 diabetes mellitus (14) Blood glucose abnormal (8) Diabetes mellitus inadequate control (8) Gestational diabetes (8)

Other Drugs Used for Diabetes mellitus management

CANAGLIFLOZIN (257) METFORMIN (120) SITAGLIPTIN (86) SEMAGLUTIDE (77) INSULIN GLARGINE (74) EMPAGLIFLOZIN (66) TIRZEPATIDE (60) DULAGLUTIDE (58) METFORMIN\SITAGLIPTIN (41) INSULIN ASPART (29)

Related Pages

INSULIN GLULISINE Full Profile All Diabetes mellitus management Drugs INSULIN GLULISINE Demographics INSULIN GLULISINE Timeline